ArticleCold Spring Harbor molecular case studies2018

Exceptional response to everolimus in a novel tuberous sclerosis complex-2 mutation-associated metastatic renal-cell carcinoma.

Samer Alsidawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.